Zachary L. Reitz

Zachary L. Reitz

Auto-generated profile, based on publicly available information

Zachary L. Reitz

Bioinformatics Group, Wageningen University

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2023 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
KBKai Blin
Kai Blin
SSSimon Shaw
Simon Shaw
HAHannah E Augustijn
Hannah E Augustijn
ZRZachary L Reitz
Zachary L Reitz
FBFriederike Biermann
Friederike Biermann
TWTilmann Weber
Tilmann Weber
Microorganisms produce small bioactive compounds as part of their secondary or specialised metabolism. Often, such metabolites have antimicrobial, anticancer, antifungal, antiviral or other bio-activities and thus play an important role for applications in medicine and agriculture. In the past decade, genome mining has become a widely-used method to explore, access, and analyse the available biodiversity of these compounds. Since 2011, the ‘antibiotics and secondary metabolite analysis shell—antiSMASH’ (https://antismash.secondarymetabolites.org/) has supported researchers in their microbial genome mining tasks, both as a free to use web server and as a standalone tool under an OSI-approved open source licence. It is currently the most widely used tool for detecting and characterising biosynthetic gene clusters (BGCs) in archaea, bacteria, and fungi. Here, we present the updated version 7 of antiSMASH. antiSMASH 7 increases the number of supported cluster types from 71 to 81, as well as containing improvements in the areas of chemical structure prediction, enzymatic assembly-line visualisation and gene cluster regulation.

25 April 2025 in Nucleic Acids Research
Verified
Journal Article
Open access
KBKai Blin
Kai Blin
SSSimon Shaw
Simon Shaw
LVLisa Vader
Lisa Vader
JSJudit Szenei
Judit Szenei
ZRZachary L Reitz
Zachary L Reitz
TWTilmann Weber
Tilmann Weber
Microorganisms synthesize small bioactive compounds through their secondary or specialized metabolism. Those compounds play an important role in microbial interactions and soil health, but are also crucial for the development of pharmaceuticals or agrochemicals. Over the past decades, advancements in genome sequencing have enabled the identification of large numbers of biosynthetic gene clusters directly from microbial genomes. Since its inception in 2011, antiSMASH (https://antismash.secondarymetabolites.org/), has become the leading tool for detecting and characterizing these gene clusters in bacteria and fungi. This paper introduces version 8 of antiSMASH, which has increased the number of detectable cluster types from 81 to 101, and has improved analysis support for terpenoids and tailoring enzymes, as well as improvements in the analysis of modular enzymes like polyketide synthases and nonribosomal peptide synthetases. These modifications keep antiSMASH up-to-date with developments in the field and extend its overall predictive capabilities for natural product genome mining.

18 November 2022 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
BTBarbara R Terlouw
Barbara R Terlouw
KBKai Blin
Kai Blin
JNJorge C Navarro-Muñoz
Jorge C Navarro-Muñoz
NANicole Avalon
Nicole Avalon
MCMarc Chevrette
Marc Chevrette
MMMarnix H. Medema
Marnix H. Medema
With an ever-increasing amount of (meta)genomic data being deposited in sequence databases, (meta)genome mining for natural product biosynthetic pathways occupies a critical role in the discovery of novel pharmaceutical drugs, crop protection agents and biomaterials. The genes that encode these pathways are often organised into biosynthetic gene clusters (BGCs). In 2015, we defined the Minimum Information about a Biosynthetic Gene cluster (MIBiG): a standardised data format that describes the minimally required information to uniquely characterise a BGC. We simultaneously constructed an accompanying online database of BGCs, which has since been widely used by the community as a reference dataset for BGCs and was expanded to 2021 entries in 2019 (MIBiG 2.0). Here, we describe MIBiG 3.0, a database update comprising large-scale validation and re-annotation of existing entries and 661 new entries. Particular attention was paid to the annotation of compound structures and biological activities, as well as protein domain selectivities. Together, these new features keep the database up-to-date, and will provide new opportunities for the scientific community to use its freely available data, e.g. for the training of new machine learning models to predict sequence-structure-function relationships for diverse natural products. MIBiG 3.0 is accessible online at https://mibig.secondarymetabolites.org/.

16 September 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ZRZachary L. Reitz
Zachary L. Reitz
CHClifford D. Hardy
Clifford D. Hardy
JSJaewon Suk
Jaewon Suk
JBJean Bouvet
Jean Bouvet
ABAlison Butler
Alison Butler
Genome mining of biosynthetic pathways streamlines discovery of secondary metabolites but can leave ambiguities in the predicted structures, which must be rectified experimentally. Through coupling the reactivity predicted by biosynthetic gene clusters with verified structures, the origin of the β-hydroxyaspartic acid diastereomers in siderophores is reported herein. Two functional subtypes of nonheme Fe(II)/α-ketoglutarate–dependent aspartyl β-hydroxylases are identified in siderophore biosynthetic gene clusters, which differ in genomic organization—existing either as fused domains (IβHAsp) at the carboxyl terminus of a nonribosomal peptide synthetase (NRPS) or as stand-alone enzymes (TβHAsp)—and each directs opposite stereoselectivity of Asp β-hydroxylation. The predictive power of this subtype delineation is confirmed by the stereochemical characterization of β-OHAsp residues in pyoverdine GB-1, delftibactin, histicorrugatin, and cupriachelin. The l-threo (2S, 3S) β-OHAsp residues of alterobactin arise from hydroxylation by the β-hydroxylase domain integrated into NRPS AltH, while l-erythro (2S, 3R) β-OHAsp in delftibactin arises from the stand-alone β-hydroxylase DelD. Cupriachelin contains both l-threo and l-erythro β-OHAsp, consistent with the presence of both types of β-hydroxylases in the biosynthetic gene cluster. A third subtype of nonheme Fe(II)/α-ketoglutarate–dependent enzymes (IβHHis) hydroxylates histidyl residues with l-threo stereospecificity. A previously undescribed, noncanonical member of the NRPS condensation domain superfamily is identified, named the interface domain, which is proposed to position the β-hydroxylase and the NRPS-bound amino acid prior to hydroxylation. Through mapping characterized β-OHAsp diastereomers to the phylogenetic tree of siderophore β-hydroxylases, methods to predict β-OHAsp stereochemistry in silico are realized. Significance Bacteria produce siderophores to sequester iron(III). Genome mining of nonribosomal peptide synthetases predicts partial structures of peptidic siderophores; however, current tools cannot reliably predict which aspartate and histidine residues will be hydroxylated to form bidentate chelating groups, nor the resulting stereochemistry. We identified 2 functional subtypes of nonheme Fe(II)/α-ketoglutarate–dependent aspartyl β-hydroxylases in siderophore biosynthetic gene clusters and one type of histidyl β-hydroxylase. Stand-alone genes encode one class of aspartyl β-hydroxylases and the histidyl β-hydroxylases, while the second class of aspartyl β-hydroxylases is encoded within a domain of a nonribosomal peptide synthetase (NRPS) gene. Each aspartyl β-hydroxylase subtype effects distinct diastereoselectivity. Mapping the β-OHAsp diastereomers in siderophores to the phylogenetic tree of β-hydroxylases enables prediction of β-OHAsp stereochemistry in silico.

30 July 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
AZAlexa M. Zytnick
Alexa M. Zytnick
SGSophie M. Gutenthaler-Tietze
Sophie M. Gutenthaler-Tietze
AAAllegra T. Aron
Allegra T. Aron
ZRZachary L. Reitz
Zachary L. Reitz
MPManh Tri Phi
Manh Tri Phi
NMNorma Cecilia Martinez-Gomez
Norma Cecilia Martinez-Gomez
Many bacteria secrete metallophores, low-molecular-weight organic compounds that bind ions with high selectivity and affinity, in order to access essential metals from the environment. Previous work has elucidated the structures and biosynthetic machinery of metallophores specific for iron, zinc, nickel, molybdenum, and copper. No physiologically relevant lanthanide-binding metallophore has been discovered despite the knowledge that lanthanide metals (Ln) have been revealed to be essential cofactors for certain alcohol dehydrogenases across a diverse range of phyla. Here, we report the biosynthetic machinery, the structure, and the physiological relevance of a lanthanophore, methylolanthanin. The structure of methylolanthanin exhibits a unique 4-hydroxybenzoate moiety which has not previously been described in other metallophores. We find that production of methylolanthanin is required for normal levels of Ln accumulation in the methylotrophic bacteriumMethylobacterium extorquensAM1, while overexpression of the molecule greatly increases bioaccumulation and adsorption. Our results provide a clearer understanding of how Ln-utilizing bacteria sense, scavenge, and store Ln; essential processes in the environment where Ln are poorly bioavailable. More broadly, the identification of this lanthanophore opens doors for study of how biosynthetic gene clusters are repurposed for additional functions and the complex relationship between metal homeostasis and fitness.

1 January 2017 in Metallomics
Verified
Journal Article
Open access
PDF file
ZRZachary L. Reitz
Zachary L. Reitz
MSMoriah Sandy
Moriah Sandy
ABAlison Butler
Alison Butler
The biosyntheses of a family of enterobactin variants – amino acid substitution, insertion, and derivatization, and macrolactone expansion – is reviewed.